Covered recipient · General Payments record
MICHAEL G JERKINS
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2021–2023
$529.26
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $309.10 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $153.66 | 10 |
| ABBVIE INC. | $58.16 | 2 |
| Otsuka America Pharmaceutical, Inc. | $26.26 | 1 |
| Exact Sciences Corporation | $15.34 | 1 |
| Amgen Inc. | $14.46 | 1 |
| Nevro Corp. | $14.02 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $13.61 | 1 |
| Lilly USA, LLC | $13.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.69 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997564401 | CMS |
| ABBVIE INC. | $29.47 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997564403 | CMS |
| Amgen Inc. | $14.46 | 10/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020641479 | CMS |
| Exact Sciences Corporation | $15.34 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026657395 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.61 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034416425 | CMS |
| Lilly USA, LLC | $13.59 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031894771 | CMS |
| Nevro Corp. | $14.02 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051663961 | CMS |
| Novo Nordisk Inc | $15.74 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002753301 | CMS |
| Novo Nordisk Inc | $18.84 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002753349 | CMS |
| Novo Nordisk Inc | $16.67 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002753323 | CMS |
| Novo Nordisk Inc | $12.84 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002711043 | CMS |
| Novo Nordisk Inc | $16.00 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002753310 | CMS |
| Novo Nordisk Inc | $12.16 | 08/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002711031 | CMS |
| Novo Nordisk Inc | $14.94 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002753289 | CMS |
| Novo Nordisk Inc | $14.79 | 10/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002711067 | CMS |
| Novo Nordisk Inc | $13.30 | 10/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002711055 | CMS |
| Novo Nordisk Inc | $18.38 | 12/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002753337 | CMS |
| Otsuka America Pharmaceutical, Inc. | $26.26 | 07/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014439869 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.